MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the launch of its Intox AI™ software platform for validation and testing. The AI-driven voice analytics solution is designed to detect intoxication and fatigue by analyzing speech patterns, and is capable of identifying indicators associated with cocaine, cannabis, alcohol, psychedelics, narcotics and human fatigue. The company said the technology is intended for deployment through Edge AI kiosks currently nearing prototype manufacturing completion.
MindBio Therapeutics is targeting commercialization opportunities in industries where drug, alcohol and fatigue testing are critical to workplace safety, including mining, aviation, construction, heavy transport and law enforcement. The company believes its voice-based screening technology could provide a faster, more scalable alternative to traditional mouth swab and breathalyzer testing while reducing costs, waste and operational complexity.
The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
For more details, the full press release is available at https://ibn.fm/Rb8yP. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
The launch of Intox AI represents a significant advancement in non-invasive testing technology. By leveraging voice analysis, the platform could streamline safety protocols in high-risk sectors, potentially reducing the time and cost associated with traditional testing methods. This innovation may also have implications for law enforcement and public safety, offering a rapid screening tool that could be deployed in various settings.
MindBio Therapeutics is a biotechnology company that is commercialising AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company is focused on developing enterprise solutions that integrate hardware and software for real-time monitoring and detection.
